CIGNA Acquires UK Foothold
Cigna will acquire FirstAssist Insurance Services, a travel and protection insurance company based in the United Kingdom, from Barclays Private Equity. The acquisition will add a new product line to Cigna's global portfolio, enabling the company to expand its individual business.
Cigna will acquire FirstAssist Insurance Services, a travel and protection insurance company based in the United Kingdom, from Barclays Private Equity. The acquisition will add a new product line to Cigna's global portfolio, enabling the company to expand its individual business. Pending regulatory approval, the acquisition is expected to close this year.
“Cigna is continually seeking opportunities to grow our business around the world - it's part of our ‘Go Deep. Go Global. Go Individual.’ strategy,” says William L. Atwell, president of Cigna International.
FirstAssist, which has 480 employees, has nearly 3 million policyholders in the UK. According to Cigna, travel in major European and Asian markets is up an average of 8% in 2010, which presents an opportunity to expand the business on a worldwide scale.
In addition to expansion into the UK, Atwell says FirstAssist brings an expanded product range that is new to Cigna's portfolio and can be offered to partners and customers in Europe and Asia, as well as doubling the number of Cigna’s affinity partners. FirstAssist maintains relationships with about 150 local, pan-European and multinational affinity partners.
Go back to the Managed Healthcare Executive eNews newsletter.
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
AI Benefits PBMs, Health Plans and Formulary Decision Making | AMCP Nexus 2024
October 21st 2024Health plans and PBMs are using AI to aggregate data, summarize information and enhance their formulary decision-making processes, according to Douglas S. Burgoyne, Pharm.D., MBA, FAMCP, adjunct associate professor at the University of Utah College of Pharmacy.
Read More
In our latest "Meet the Board" podcast episode, Managed Healthcare Executive Editors caught up with editorial advisory board member, Eric Hunter, CEO of CareOregon, to discuss a number of topics, one including the merger that never closed with SCAN Health Plan due to local opposition from Oregonians.
Listen
The Link between GLP-1 Drugs and Diabetic Retinopathy Is Not So Clear | AAO 2024
Published: October 21st 2024 | Updated: October 21st 2024Clinical and other trials for GLP-1 therapies have found an association between these drugs and diabetic retinopathy complications in patients. But this could be an early worsening of disease unrelated to treatment.
Read More
